219 related articles for article (PubMed ID: 16580304)
1. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
Lee PC; Kibbe MR; Schuchert MJ; Stolz DB; Watkins SC; Griffith BP; Billiar TR; Shears LL
Microvasc Res; 2000 Nov; 60(3):269-80. PubMed ID: 11078643
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
[TBL] [Abstract][Full Text] [Related]
6. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia.
Wang Y; Gu Y; Zhang Y; Lewis DF
Am J Obstet Gynecol; 2004 Mar; 190(3):817-24. PubMed ID: 15042020
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells.
Pan YM; Yao YZ; Zhu ZH; Sun XT; Qiu YD; Ding YT
Acta Pharmacol Sin; 2006 Dec; 27(12):1567-74. PubMed ID: 17112410
[TBL] [Abstract][Full Text] [Related]
8. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
9. Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells.
Uhlmann S; Friedrichs U; Eichler W; Hoffmann S; Wiedemann P
Microvasc Res; 2001 Sep; 62(2):179-89. PubMed ID: 11516247
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis.
Kang KH; Park SY; Rho SB; Lee JH
Cardiovasc Res; 2008 Jul; 79(1):150-60. PubMed ID: 18344519
[TBL] [Abstract][Full Text] [Related]
11. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
12. 17β-estradiol-linked nitro-L-arginine as simultaneous inducer of apoptosis in melanoma and tumor-angiogenic vascular endothelial cells.
Roy S; Reddy BS; Sudhakar G; Kumar JM; Banerjee R
Mol Pharm; 2011 Apr; 8(2):350-9. PubMed ID: 21291219
[TBL] [Abstract][Full Text] [Related]
13. Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2.
Sakkoula E; Pipili-Synetos E; Maragoudakis ME
Br J Pharmacol; 1997 Nov; 122(5):793-5. PubMed ID: 9384490
[TBL] [Abstract][Full Text] [Related]
14. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro.
Kao YH; Yu CL; Chang LW; Yu HS
Chem Res Toxicol; 2003 Apr; 16(4):460-8. PubMed ID: 12703962
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective?
Adams JA; Wu D; Bassuk J; Arias J; Lozano H; Kurlansky P; Lamas GA
Resuscitation; 2007 Sep; 74(3):516-25. PubMed ID: 17466432
[TBL] [Abstract][Full Text] [Related]
17. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
19. Endogenous production of nitric oxide contributes to proliferation effect of vascular endothelial growth factor-induced malignant melanoma cell.
Tao J; Tu YT; Li JW; Feng AP; Huang CZ; Wu Y; Shen GX
Clin Exp Dermatol; 2006 Jan; 31(1):94-9. PubMed ID: 16309495
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]